Grainger, David W.

Extracellular matrix-based biomaterial scaffolds and the host response

Aamodt, J. M., & Grainger, D. W. (2016) · Biomaterials

Tissue Engineering and Regenerative MedicineBone Tissue Engineering Materials

Cited by 509

Drug/device combinations for local drug therapies and infection prophylaxis

Wu, P., & Grainger, D. W. (2006) · Biomaterials

Bone Tissue Engineering MaterialsAdvanced Drug Delivery Systems

Cited by 491

Polysaccharide matrices used in 3D in vitro cell culture systems

Diekjürgen, D., & Grainger, D. W. (2017) · Biomaterials

Hydrogels: synthesis, properties, applications3D Printing in Biomedical Research

Cited by 125

Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models

Chamberlain, L. M., Godek, M. L., Gonzalez‐Juarrero, M., & Grainger, D. W. (2009) · Journal of Biomedical Materials Research Part A

Immune cells in cancerImmunotoxicology and immune responses

Cited by 112

Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation

Takahashi, H., Wang, Y., & Grainger, D. W. (2010) · Journal of Controlled Release

RNA Interference and Gene DeliveryTissue Engineering and Regenerative Medicine

Cited by 58

Strategies for derisking translational processes for biomedical technologies

Abou-El-Enein, M., Duda, G. N., Gruskin, E. A., & Grainger, D. W. (2017) · Trends in Biotechnology

Health and Medical Research ImpactsTechnology Assessment and Management

Cited by 36

Progesterone administration induced impairment of insulin suppression of hepatic glucose production

Nelson, T., Shulman, G., Grainger, D., & Diamond, M. P. (1994) · Fertility and Sterility

Pancreatic function and diabetesEstrogen and related hormone effects

Cited by 16